Organon & Co. (OGN) Social Stream
ORGANON & CO (OGN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering OGN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-12 | 7 | $48.001 | $35 | $39.833 | $21.67 | 83.82% |
| 2021-11-11 | 7 | $48.001 | $35 | $39.2 | $21.67 | 80.9% |
| 2021-12-15 | 7 | $48 | $35 | $39.2 | $21.67 | 80.9% |
| 2022-01-13 | 7 | $48 | $35 | $39 | $21.67 | 79.97% |
| 2022-02-07 | 7 | $46 | $35 | $38.666 | $21.67 | 78.43% |
| 2022-02-17 | 7 | $44 | $35 | $38.8 | $21.67 | 79.05% |
| 2022-03-08 | 7 | $44 | $35 | $38.666 | $21.67 | 78.43% |
| 2022-04-25 | 7 | $44 | $35 | $39.166 | $21.67 | 80.74% |
| 2022-05-05 | 7 | $44 | $35 | $39 | $21.67 | 79.97% |
| 2022-05-23 | 8 | $44 | $35 | $39.142 | $21.67 | 80.63% |
| 2022-06-15 | 7 | $44 | $35 | $39.142 | $21.67 | 80.63% |
| 2022-07-18 | 7 | $44 | $34 | $38.428 | $21.67 | 77.33% |
| 2022-08-01 | 7 | $41 | $34 | $38 | $21.67 | 75.36% |
| 2022-08-19 | 7 | $41 | $35 | $37.714 | $21.67 | 74.04% |
| 2022-09-17 | 7 | $41 | $34 | $37.285 | $21.67 | 72.06% |
| 2022-10-12 | 7 | $41 | $27 | $36.142 | $21.67 | 66.78% |
| 2022-10-14 | 7 | $41 | $25 | $34.428 | $21.67 | 58.87% |
| 2022-11-04 | 7 | $40 | $24 | $33.428 | $21.67 | 54.26% |
| 2023-01-05 | 7 | $40 | $22 | $32.285 | $21.67 | 48.98% |
| 2023-02-13 | 7 | $40 | $24 | $32.571 | $21.67 | 50.3% |
| 2023-02-17 | 7 | $40 | $24 | $32.428 | $21.67 | 49.64% |
| 2023-03-15 | 8 | $40 | $24 | $32.5 | $21.67 | 49.98% |
The Trend in the Analyst Price Target
OGN's average price target has moved down $9.3 over the prior 18 months.
Over the past 49 weeks, OGN's average upside potential has been 20.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-19 | 7 | 44 | 35 | 39.166 | 33.95 | 15.36% |
| 2022-07-18 | 7 | 44 | 34 | 38.428 | 31.20 | 23.17% |
| 2022-08-13 | 7 | 41 | 35 | 37.714 | 30.99 | 21.7% |
| 2022-11-29 | 7 | 40 | 24 | 32.571 | 24.94 | 30.6% |
| 2023-01-10 | 7 | 40 | 24 | 32.571 | 30.12 | 8.14% |
OGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.25 | 3 | 1 | 3 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
OGN's average broker recommendation rating worsened by 0.39 over the prior 43 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ORGANON & CO fares relative to all US stocks, note that its variance in analysts' estimates is lower than -674.92% of that group.
- ORGANON & CO's upside potential (average analyst target price relative to current price) is greater than 686.98% of Pharmaceutical Products stocks.
- ORGANON & CO's average analyst price target is higher than 1326.85% of Pharmaceutical Products stocks.
- OGN has a higher number of analysts covering the stock than 1038.18% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, LYEL, VERV, and ATAI are the three stocks most similar to ORGANON & CO regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is OGN a Buy, Hold or Sell? See the POWR Ratings now!